Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Patients with giant cell arteritis have a greater risk for aortic complications than those with polymyalgia rheumatica.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q antibodies and urinary erythrocytes have the best predictive power to dist ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

Early-life mutagenic exposure to colibactin-producing bacteria may be associated with the increased incidence of early-onset colorectal cancer.

This patient perspectives interview features Stacy Courtnay, who shared her experience managing rheumatoid arthritis during ...

Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.

More US children have died from the flu this season than in any year since the 2009 swine flu pandemic, according to a new federal report.

Type 1 diabetes was associated with an elevated risk for osteoporotic fracture regardless of femoral neck bone mineral density.

Hospital-onset antimicrobial-resistant infections increased across US hospitals during and beyond the COVID-19 pandemic.

Combination rituximab and IVIG therapy may be a viable treatment option for patients with refractory autoimmune diseases, though the quality of evidence is low.